ARDS - Aridis Pharmaceuticals misses by $0.06 beats on revenue May, 14 2019 04:42 PM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals (NASDAQ:ARDS): Q1 GAAP EPS of -$0.99 misses by $0.06.More news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...